Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Cancer. 2001 Oct;1(1):34-45.

The development of androgen-independent prostate cancer.

Author information

  • 1Department of Medicine, Stanford University School of Medicine, California 94305-5103, USA. feldman@cmgm.stanford.edu

Abstract

The normal prostate and early-stage prostate cancers depend on androgens for growth and survival, and androgen ablation therapy causes them to regress. Cancers that are not cured by surgery eventually become androgen independent, rendering anti-androgen therapy ineffective. But how does androgen independence arise? We predict that understanding the pathways that lead to the development of androgen-independent prostate cancer will pave the way to effective therapies for these, at present, untreatable cancers.

PMID:
11900250
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk